Manvi Biopharma Pvt. Ltd. Walk In Interview for QC, R&D & QA, Warehouse, Human Resource, EHS on 12th & 14th Dec’ 2022
WALK IN-INTERVIEW
MANVI BIOPHARMA PRIVATE LIMITED
We are looking for the following professionals for our Manufacturing Unit, QC, R&D & QA Urgent Requirement)
Department : Quality Control, Quality Assurance, Warehouse, Human Resource, EHS, R&D
Designation : Chemist / Sr.Chemist/ Executive
Experience : 1-5 Years
Vacancies : 46 positions
Qualification : B.Sc Chemistry/ M.Sc Organic Chemistry
Work location Manufacturing site : Fugen Laboratories Pvt. Ltd (A subsidiary of Manvi Biopharma Pvt. Ltd), Mandollagudem (V), Choutuppal (M).
Yadadribhuvanagiri (Dt)-508 252. Telangana state. India.
Date & Time of Walk in : 12th & 14th Dec’ 2022
(10:00 am-03:00 pm)
Interview Venue : Manvi Biopharma Pvt. Ltd. Plot #186 B, IDA, Mallapur, Hyderabad-500 076, Telangana State. India
Fresher’s 2021/2022 Passed out only Eligible
Salary will not be a constraint for deserving candidates
Contact No: 9951015911,9154775242 &7799227713
(Email id: venkatesh@manvibiopharma.com) & qa@manvibiopharma.com
Please Note: Candidates are requested to bring updated resume, Photo copies of all educational certificates, Latest increment latter, Last three months’ pay slips/Last three Months bank statement & Aadhar card copy.
Company website : www.ManviBiopharma.com
Similar Post..
Macleods Pharmaceutical Walk-In Drive at Indore for Baddi & Sikkim Location on 16th December 2022

- Pharma Job Openings at Innoxel Lifesciences – Walk-In Interview on June 8, 2025
- FDA Advises Consumers Not to Inhale Nitrous Oxide Products
- Gland Pharma Walk-In Interview for IPQA Department – 6th June
- Maithri Drugs Files 71st USDMF for Trospium Chloride, Expands Urology API Portfolio
- Join Neuland Laboratories: Walk-In Drive for Production, QC, QA Roles on 7th June
- Indian-origin pharma tycoon arrested in US for healthcare fraud
- Freshers & Experienced Hiring at Vital Therapeutics – Walk-In for Production Roles, June 6–7
- Gland pharma walk in interview for Production Department on 6th june
- SPARC shares fall 18% after Sun Pharma’s key psoriasis drug fails to get desired outcome
- Trump drug pricing order to have limited credit impact on Indian pharma: CRISIL
- FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
- India’s pharma funding falls by over 90% YoY in April 2025